446 related articles for article (PubMed ID: 20952071)
1. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
[TBL] [Abstract][Full Text] [Related]
2. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
3. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R
Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody.
Vani J; Nayak R; Shaila MS
Immunology; 2007 Apr; 120(4):486-96. PubMed ID: 17229267
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
7. Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody.
Fernández-Marrero Y; Hernández T; Roque-Navarro L; Talavera A; Moreno E; Griñán T; Vázquez AM; de Acosta CM; Pérez R; López-Requena A
Mol Immunol; 2011 Apr; 48(8):1059-67. PubMed ID: 21306777
[TBL] [Abstract][Full Text] [Related]
8. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
Margaritte C; Gilbert D; Brard F; Tron F
J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
[TBL] [Abstract][Full Text] [Related]
10. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
11. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides, Ab1 and Ab2 antibodies IV. Dominance of VH domain in the induction of anti-idiotypic antibodies by gene gun immunization.
López-Requena A; Mateo de Acosta C; Bestagno M; Vázquez AM; Pérez R; Burrone OR
Mol Immunol; 2007 Apr; 44(11):3070-5. PubMed ID: 17337302
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
14. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
Kawahara DJ; Marrack P; Kappler JW
J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
[TBL] [Abstract][Full Text] [Related]
15. VH-related idiotopes detected by site-directed mutagenesis. A study induced by the failure to find CD4 anti-idiotypic antibodies mimicking the cellular receptor of HIV.
Weissenhorn W; Chen YH; Riethmüller G; Rieber EP; Weiss EH
J Immunol; 1992 Aug; 149(4):1237-41. PubMed ID: 1500715
[TBL] [Abstract][Full Text] [Related]
16. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
17. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
18. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
19. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping and use of anti-idiotypic antibodies to the L6 monoclonal anticarcinoma antibody.
Hellström KE; Yelton DE; Fell HP; Beaton D; Gayle M; MacLean M; Kahn M; Hellström I
Cancer Res; 1990 Apr; 50(8):2449-54. PubMed ID: 1690598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]